4.0 Article

Impact of Sex Disparities on Outcomes of Living-Donor Kidney Transplant in Egypt: Data of 979 Patients

期刊

EXPERIMENTAL AND CLINICAL TRANSPLANTATION
卷 16, 期 2, 页码 133-137

出版社

BASKENT UNIV
DOI: 10.6002/ect.2016.0253

关键词

Graft survival; Renal transplant; Survival

向作者/读者索取更多资源

Objectives: Renal transplant is the criterion standard for treatment of end-stage renal disease. The effects of disparities between men and women on renal transplant outcomes have been evaluated in many studies but with debatable results. It has been suggested that female kidney donors have poor outcomes after transplant compared with male kidney donors, especially when implanted in a male recipient. The aim of the study was to evaluate the effects of sex on living-donor kidney transplant outcome. Materials and Methods: The data of 979 patients who underwent living-donor kidney transplant from January 2000 to December 2010 at a single center were reviewed retrospectively. The patients were divided into 4 groups according to recipient and donor sex: male donor-tomale recipient (n = 307), male donor-to-female recipient (n = 132), female donor-to-male recipient (n = 411), and female donor-to-female recipient (n = 129). We compared the demographic characteristics, post transplant rejection and complications, and graft and patient survival rates among the groups. Results: Male recipients were older than female recipients, whereas male donors were younger than female donors (P<.001). No statistically significant differences were shown regarding recipient body mass index, ischemia time and time to diuresis, and acute and chronic rejection rates between the groups. Graft (P=.947) and patient (P=.421) survival rates were comparable between groups. Conclusions: Donor and recipient sex had no significant effect on outcomes of living-donor renal allograft recipients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Immunology

Renal Transplantation in Mansoura, Egypt

Mohamed A. Bakr, Ahmed B. Shehab El-Dein, Ayman F. Refaie, Ahmed A. Shokeir, Hussein A. Sheashaa, Bedeir Ali-El-Dein, Tarek El-Diasty, Amani M. Ismail, Mohamed A. Ghoneim

TRANSPLANTATION (2020)

Article Pharmacology & Pharmacy

CYP3A5Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients

Effrosyni Mendrinou, Mohamed Elsayed Mashaly, Amir Mohamed Al Okily, Mohamed Elsayed Mohamed, Ayman Fathi Refaie, Essam Mahmoud Elsawy, Hazem Hamed Saleh, Hussein Sheashaa, George P. Patrinos

FRONTIERS IN PHARMACOLOGY (2020)

Review Immunology

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations

Ayman F. Refaie, Batoul L. Elbassiouny, Malgorzata Kloc, Omaima M. Sabek, Sherry M. Khater, Amani M. Ismail, Rania H. Mohamed, Mohamed A. Ghoneim

Summary: MSC-based therapy for T1DM shows promise, but there are conflicting views on their immunological profile. Research focuses on understanding the mechanisms of their immunomodulatory functions and exploring ways to enhance their effects.

FRONTIERS IN IMMUNOLOGY (2021)

Article Transplantation

Death With a Functioning Graft Kidney: A Single-Center Experience of More Than 4 Decades

Mostafa Gamal, Ahmed M. Salah, Yasser A. Hendy, Ahmed F. Donia, Ayman F. Refaie

Summary: This study examined death with graft function in kidney transplant patients over a period of more than four decades. Male sex, pretransplant diabetes, steroid dose, and posttransplant infections were identified as significant risk factors for death with graft function. The most common causes of this event were cardiovascular disease, infections, and malignancy. Attention should be given to reducing cardiovascular disease risk factors, updating posttransplant vaccination policies, and increasing surveillance for malignancy, as well as adopting less aggressive immunosuppression regimens.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION (2022)

Review Endocrinology & Metabolism

Management of osteoporosis in patients with chronic kidney disease

M. Abdalbary, M. Sobh, S. Elnagar, M. A. Elhadedy, N. Elshabrawy, M. Abdelsalam, K. Asadipooya, A. Sabry, A. Halawa, A. El-Husseini

Summary: Patients with chronic kidney disease (CKD) have a higher risk of fractures due to compromised bone quantity and/or quality. Fractures have a negative impact on the quality of life and mortality of CKD patients. The pathogenesis of bone loss and fracture in CKD is complex and multi-factorial. There is no consensus on the optimal diagnostic method for assessing bone quantity in CKD patients. Understanding the mechanism of bone loss is crucial for preventing fractures in CKD patients. Several non-pharmacological and therapeutic interventions have been reported to improve bone health, but their safety and efficacy in advanced CKD patients are uncertain. There is a significant gap in osteoporosis management in CKD patients.

OSTEOPOROSIS INTERNATIONAL (2022)

Article Cell & Tissue Engineering

Transplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice

Mohamed A. Ghoneim, Mahmoud M. Gabr, Ayman F. Refaie, Sawsan M. El-Halawani, Mohga M. Al-issawi, Batoul L. Elbassiouny, Mai A. Abd El Kader, Amani M. Ismail, Mona F. Zidan, Mary S. Karras, Raghda W. Magar, Sherry M. Khater, Sylvia A. Ashamallah, Mahmoud M. Zakaria, Malgorzata Kloc

Summary: This study investigated allogenic immune responses following the transplantation of insulin-producing cells (IPCs) differentiated from human adipose tissue-derived stem cells (hAT-MSCs) into humanized mice. The results showed that the engrafted cells were not affected by allogenic immune response, suggesting potential for cell therapy for insulin-dependent diabetes without immunosuppression or encapsulation.

STEM CELL RESEARCH & THERAPY (2022)

Meeting Abstract Urology & Nephrology

In the era of computed tomography volumetry: Is isotope renography still routinely required in the preparation and selection of living kidney donors?

B. Ali-El-Dein, A. Galal, M. H. Zahran, H. Refaie, M. E. Mashaly, M. T. Fouad, A. F. Refaie, I Saeed, M. Atteya, Y. Osman

EUROPEAN UROLOGY (2022)

Meeting Abstract Transplantation

DEATH WITH GRAFT FUNCTION AMONG EGYPTIAN KIDNEY TRANSPLANT RECIPIENTS: A SINGLE CENTER EXPERIENCE

Mostafa Gamal, Ahmed Mohamed Salah, Yasser Hendy, Ayman Refaie

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Article Medicine, General & Internal

Treatment Outcomes of Proliferative vs. Non-proliferative Adult Lupus Nephritis: A 10-Year Follow-Up

Mohamed Zahab, Mohammed A. Fouda, Yasser Elhendy, Amir Elokely, Mona Abdul Rahim, Ayman F. Refaie, Sami Alobaidi, Ahmed Akl

Summary: This study included 402 SLE cases with lupus nephritis, finding that impaired renal function, proteinuria, and LN class were the most relevant prognostic factors for renal survival among Egyptian LN patients.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Article Urology & Nephrology

Impact of Therapeutic Dose Monitoring of Mycophenolic Acid on the Outcome of Live-Donor Kidney Transplant Recipients-A Prospective Controlled Study

Ahmed Abdelfattah Denewar, Ezzat Mostafa Mohamed, Mabrouk Ibrahim M. Ismael, Amani Mostafa Ismail, Ayman Fathi Refaie

Summary: Immunosuppressive therapy is crucial for renal transplantation to balance the immune response and reduce the risk of rejection and infection. Adopting therapeutic dose monitoring strategy during follow-up of kidney transplant recipients can help reduce certain side effects and improve graft survival. Longer-term studies with larger sample sizes are needed to further support this approach.

SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2021)

Review Urology & Nephrology

COVID-19 in Renal Transplant Recipients: Case Series and a Brief Review of Current Evidence

Muhammed Ahmed Elhadedy, Yazin Marie, Ahmed Halawa

Summary: By April 26, 2020, there were 203,818 reported deaths worldwide from COVID-19, affecting people in 210 countries. This study discusses the outcomes of COVID-19 in kidney transplant recipients, reporting 8 cases with common presenting symptoms of fever and cough. Treatment included supportive care and discontinuation of immunosuppressive drugs, resulting in the recovery of most patients and reduced burden on healthcare services.

NEPHRON (2021)

Article Oncology

The previously common post-kidney transplant Kaposi sarcoma has become non-existent for a decade: an Egyptian experience

Ahmed Farouk Donia, Mohammed Ashraf Fouda, Moatasem Elsayed Ghoneim, Ayman Fathi Refaie, Bedeir Ali-El-Dein

Summary: Kaposi sarcoma, previously the most common malignancy among kidney transplant recipients, has not been observed for almost a decade. Factors such as m-TOR inhibitors, steroid-free regimen, and CMV prophylaxis policy may have contributed to the disappearance of Kaposi sarcoma. However, only CMV prophylaxis policy showed statistically significant relation to the disappearance of Kaposi sarcoma.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Cell & Tissue Engineering

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges

Mohamed A. Ghoneim, Ayman F. Refaie, Batoul L. Elbassiouny, Mahmoud M. Gabr, Mahmoud M. Zakaria

STEM CELL REVIEWS AND REPORTS (2020)

Meeting Abstract Transplantation

CORONARY ARTERY CALCIFICATION AMONG RENAL TRANSPLANT RECIPIENTS

Mohamed Osama, Medhat Mahmoud, Salem El Deeb, Ahmed Elmowafy, Hussein Sheashaa, Ahmed Donia, Ayman Refaie, Ashraf Fouda

NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)

Meeting Abstract Transplantation

UNPOPULAR SOLUTIONS FOR VASCULAR ACCESS DIFFICULTIES IN HEMODIALYSIS PATIENTS: A CASE SERIES

Ahmed Mohamed Naguib Attiya, Samar Elshahat, Ibrahim Galalah, Ahmed Elmowafy, Khaled Eldahshan, Salwa Elwasif, Ayman Refaie

NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)

暂无数据